1. Introduction {#sec1}
===============

Nipple discharge is the third most common symptom presenting to breast clinics, following lumps and pain \[[@B1]\], accounting for 3 to 10% of referrals \[[@B2]\]. Nipple discharge causes considerable anxiety, but it is a presenting symptom in only 5 to 12% of cases of breast cancer \[[@B2]\]. Suspicious discharge is described as being unilateral, single duct, spontaneous, and persistent \[[@B3]\]. Discharge that is clear, serous, sero-sanguinous, or bloodstained is more likely to be due to breast cancer \[[@B4]\].

Approximately, 55% of patients presenting with nipple discharge have an associated mass, 19% of which are malignant \[[@B3]\]. These patients should be investigated by the triple assessment. In some patients who do not have a palpable breast lesion, mammography identifies an abnormality which requires further investigation. The remainder will have neither a palpable nor a radiological abnormality. Where the nature of the discharge is suspicious, duct excision is required to exclude breast cancer.

Although not routine practice in the United Kingdom, a number of techniques have been used to determine the cause of nipple discharge, beyond the triple assessment. Nipple discharge cytology has a low sensitivity for the detection of breast cancer \[[@B4], [@B5]\] and is unlikely to alter the management of patients with nipple discharge \[[@B4], [@B6]\]. Fluorescent insitu hybridization analysis of the discharge has not yet entered clinical practice however, a small pilot study has shown that it has a 100% specificity in making a definitive diagnosis of malignancy in patients with indeterminate cytologic results, suggesting that it could be a good adjunct to cytology \[[@B7]\].

Ductography has a high-positive predictive factor in the diagnosis of intraductal lesions, papilloma, and carcinoma; however, it has a low sensitivity and is painful \[[@B8]\]. Breast ductoscopy is an evolving technology, which is a promising tool as it can allow identification of the site of any lesion in younger women, allowing excision of the benign lesions while retaining the ability to lactate. However, further studies are required to define its role more clearly, as there are still limitations in clinical practice \[[@B8]--[@B15]\]. Magnetic resonance imaging (MRI) may play an adjunctive role, aiding in the differentiation of benign ductal abnormalities from malignant ones but remains under investigation and is not the method of choice presently in evaluating nipple discharge in the UK \[[@B16]--[@B19]\].

Only duct excision provides a definitive histological diagnosis and remains the gold standard. However, a significant number of patients with benign conditions undergo surgery, which is a concern particularly in women of child bearing age due to the implications associated with breastfeeding. The aim of this study was to analyse our experience of duct excision for nipple discharge, in an attempt to identify features that raise the suspicion of breast cancer, and to identify features indicative of benign disease where duct excision can be avoided.

2. Methods {#sec2}
==========

All patients who underwent microdochectomy or total duct excision for spontaneous nipple discharge between 1995 and 2005 were analysed. Patients were managed by two consultant breast surgeons, who performed or supervised all surgical procedures. Data that was collected prospectively on the British Association of Surgical Oncology Database was retrieved and analysed.

During this period, 1964 patients presented with spontaneous nipple discharge, either alone or in combination with other symptoms. Triple assessment diagnosed breast cancer in 62 patients and benign causes in 1708. In the absence of a clinical or radiological abnormality to allow a definite benign or malignant diagnosis, duct excision was performed if the nature of the discharge caused concern.

One hundred and ninety-four patients, including 1 man, underwent duct excision for spontaneous nipple discharge alone, median age 51, range 17--88 years ([Figure 1](#fig1){ref-type="fig"}). Two women had a previous history of breast carcinoma; both presented with discharge on the contralateral side to a previous mastectomy. Fifty-eight patients had a past history of benign breast disease.

3. Results {#sec3}
==========

One hundred and ninety-four duct excisions were performed for spontaneous nipple discharge alone, 135 total duct excision, and 59 microdochectomies. Breast cancer was identified in 11 (5.7%) patients: 4 invasive and 7 insitu ([Table 1](#tab1){ref-type="table"}). Duct ectasia and duct papilloma were the most common benign diagnoses.

The median age of patients found to have bloodstained discharge diagnosed to be breast cancer was 68 with a range of 32--88. This was higher than that for patients who were found to have benign disease, median age 50 with a range 17--84 years for patients with benign disease.

All patients diagnosed with breast cancer, following duct excision ([Table 2](#tab2){ref-type="table"}), subsequently underwent mastectomy with either axillary sampling or clearance. One patient was initially treated by central wide local excision, but disease-free margins could not be obtained. All 4 cases of invasive carcinoma were grade 2 or 3 invasive ductal with associated ductal carcinoma insitu. Two cases of DCIS were high grade, 4 intermediate grade, and 1 low grade. Nodal involvement was not identified in any cases. There were no major discrepancies between the histological diagnoses from the duct excision and the subsequent therapeutic surgery, in 1 case, the grade of DCIS was increased from low to intermediate. None of these patients developed recurrent disease during the 24--130 months followup.

Ten patients with breast cancer had unilateral single-duct discharge, 1 had unilateral multiple duct discharge and was found to have extensive intermediate grade DCIS. All 11 patients had some form of bloodstained discharge: 9 frankly bloodstained discharge, 1 altered blood, and 1 serous discharge that was positive for blood on dipstick testing. Discharge due to malignant disease was significantly more likely to be bloodstained than that due to benign causes (Fisher\'s exact test, 2-tailed *P* value = 0.001).

One hundred and eight patients (56%) who underwent duct excision had bloodstained discharge. The median age of patients with bloodstained discharge was higher than those with nonbloodstained discharge: 55, range 24--88 years, versus 47, range 17--74 years, but did not reach statistical significance (Mann-Whitney test, *P* = 0.295).

Eleven of the 108 (10.2%) patients who had some form of bloodstained nipple discharge were found to have invasive or insitu breast cancer following duct excision ([Table 3](#tab3){ref-type="table"}). No cases of coloured discharge were associated with cancer.

Three patients were found to have atypical duct hyperplasia (ADH), of which 2 had frank bloodstained discharge and 1 serous discharge with blood on dipstick testing.

Eight women with benign pathology at duct excision have subsequently developed invasive breast cancer, 4 in the ipsilateral and 4 in the contralateral breast, including 2 of the 3 with ADH ([Table 4](#tab4){ref-type="table"}). Based on the national registration rate for breast cancer, in the 50--54 age group, (the median age of patients in this study), in 2001 (the midpoint of this study), 3.2 breast cancers would be expected to develop during the median follow-up period of 6 years \[[@B20]\].

A further 24 women with benign pathology at duct excision reattended the Breast Clinic. Eighteen had symptoms on the same side as the duct excision, 4 contralateral, and 2 bilateral (1 multiple papillomatosis and 1 requesting bilateral reduction mammoplasty). The symptoms and signs at representation were similar to the original pathologies in 13 (54.2%), which was most commonly sepsis, previous surgery having demonstrated subclinical periductal mastitis.

4. Discussion {#sec4}
=============

The management of patients with spontaneous bloodstained nipple discharge in the absence of other detectable abnormalities remains controversial. Reports have not shown an increased risk of breast cancer in patients with nipple discharge, with no other abnormality on triple assessment \[[@B21]\]. Several policies have been proposed, including conservative management \[[@B22]\], or surgery for patients with suspicious or bothersome discharge \[[@B4], [@B21]\].

Our findings do not support a policy of conservative management of spontaneous bloodstained nipple discharge, as 10.2% of patients were diagnosed to have breast cancer in the absence of other clinical or radiological abnormality. The median age of patients with bloodstained discharge due to breast cancer was higher than that of the patients with benign disease (68 versus 55 years) but with a large overlap of ages. It has been suggested that a conservative policy could be adopted for women under the age of 40 years \[[@B2]\]. However, in our series this would have led us to missing a case of widespread intermediate grade DCIS that necessitated mastectomy. From our data it would appear appropriate to advocate conservative management for women under 30, but this would only have avoided 9 of 194 operations.

Locker et al. \[[@B23]\] advocated conservative management of patients with all types of nipple discharge, suggesting reinvestigation 1 year after presentation. They claimed that any breast cancer not identified at presentation would still be at a very early stage when a clinical or radiological abnormality became apparent, which would not adversely affect the outcome. If this had been applied to our series, four women with grade 2 invasive breast carcinoma would have had a delayed diagnosis. It is not possible to predict when their cancers would have become clinically or radiologically detectable or what effect that this would have had on prognosis, but a delay in diagnosing breast cancer of more than three months is considered to have prognostic significance \[[@B24]\]. Reviews have reported that DCIS progresses to invasive cancer in 14--53% of cases over a period of at least 10 years \[[@B25]\], that DCIS presenting with nipple discharge tends to be extensive and has a high rate of local recurrence if treated with breast conservation \[[@B26]\], and that higher grades of DCIS are more likely to recur and to progress to high-grade invasive disease \[[@B27]\]. Only 1 patient had low-grade DCIS which would not support a policy of conservative management.

Atypical ductal hyperplasia is associated with a risk of developing breast carcinoma of around 10% within 10 years \[[@B2]\]. Two of the 3 women were found to have ADH following duct excision developed breast cancer within 4 years, 1 in the contralateral breast. This raises the question of whether symptomatic ADH may impart a higher risk of developing breast cancer than incidentally identified ADH. Little data is available, but ADH associated with DCIS has been reported to increase the risk of contralateral breast cancer above that of DCIS alone, and clear surgical margins at duct excision for ADH did not affect the risk of developing breast cancer \[[@B28]\].

A further 6 women, 4 of who had presented with spontaneous bloodstained or serous discharge diagnosed with benign diagnoses following duct excision, have gone on to develop breast cancer, 3 in the contralateral breast. This would suggest that presenting with bloodstained or serous discharge may also be a marker of an increased risk of subsequently developing breast cancer.

Dipstick testing of nipple discharge, for occult blood, to identify those who require duct excision has been described \[[@B29], [@B30]\]. Dipsticks are very sensitive, but are of low specificity. We only use them when a patient clearly gives a history of bloodstained discharge that is not confirmed on clinical examination, and then only accept +++ reading as a positive test. In our series, 1 woman with breast cancer did not have frank bloodstained discharge on clinical examination. She gave a clear history of previously having blood in the discharge, and the serous discharge identified on examination tested positive for blood on dipstick testing.

The management of spontaneous bloodstained nipple discharge remains open to optimisation. We believe that all cases of demonstratable spontaneous bloodstained discharge in patients over the age of 30 years should undergo diagnostic duct excision. However, duct excision should be avoided in the absence of blood staining in order to prevent unnecessary surgery and possible complications, as no patients were identified to have breast cancer.

![Age distribution of patients undergoing surgery for spontaneous isolated nipple discharge.](IJBC2011-495315.001){#fig1}

###### 

Histology of duct excision specimens.

  Histology              Number   \% of total (195)   Median age (range)
  ---------------------- -------- ------------------- --------------------
  *Malignant*            11       6%                  68 (32--88)
   IDC                   4        2%                  72 (68--74)
   DCIS                  7        4%                  59 (32--88)
  *Benign*               183      94%                 50 (17--84)
   Duct ectasia          76       39%                 50 (22--84)
   Papilloma             65       34%                 56 (26--84)
   Periductal mastitis   21       11%                 39 (17--59)
   Fibrocystic disease   12       6%                  48 (35--65)
   ADH                   3        1%                  61 (35--76)
   Normal                6        3%                  43 (24--67)

IDC: invasive ductal carcinoma.

DCIS: ductal carcinoma insitu.

ADH: atypical ductal hyperplasia.

###### 

Breast cancers identified following surgery for spontaneous isolated nipple discharge.

  Age   Discharge type                                                                Single duct?   Initial surgery   Initial histology   Final histology                       Treatment
  ----- ----------------------------------------------------------------------------- -------------- ----------------- ------------------- ------------------------------------- ------------------
  32    Fresh blood                                                                   Yes            Micro             DCIS                Intermediate grade DCIS               Mx + ANS + recon
  43    Fresh blood                                                                   No             TDE               DCIS                Extensive intermediate grade DCIS     Mx + ANS + recon
  51    Fresh blood/serous                                                            Yes            TDE               DCIS                High grade DCIS                       Mx + ANS
  58    Fresh blood                                                                   Yes            TDE               IDC                 3 mm grade 3 IDC + extensive DCIS     Mx + ANC + recon
  60    Fresh blood                                                                   Yes            Micro             DCIS                High grade DCIS                       Mx + ANS
  68    Fresh blood                                                                   Yes            TDE               IDC                 3 mm grade 2 IDC + DCIS               Mx + ANC
  69    Fresh blood                                                                   Yes            Micro             DCIS                Multifocal intermediate grade DCIS    Mx + ANS
  72    History of fresh blood; serous discharge identified, dipstick +++ for blood   Yes            TDE               IDC                 10 mm grade 2 IDC + DCIS              Mx+ ANC
  74    Altered blood                                                                 Yes            TDE               IDC                 10 mm grade 2 IDC + widespread DCIS   Mx and ANC
  78    Fresh blood                                                                   Yes            TDE               DCIS                Multifocal intermediate grade DCIS    Simple Mx
  88    Fresh blood                                                                   Yes            TDE               DCIS                Low grade DCIS                        Simple Mx

Initial operation: Micro: microdochectomy; TDE: total duct excision.

Histology: DCIS: ductal carcinoma insitu; IDC: invasive ductal carcinoma.

Treatment: Mx: mastectomy; ANS: axillary node sampling; ANC: axillary node clearance; Recon: reconstruction.

###### 

Histology compared to type of discharge.

  Histology              Number   Number with frank bloodstained discharge (% of diagnostic group)
  ---------------------- -------- ------------------------------------------------------------------
  All                    194      108 (56%)
  *Malignant*            11       11 (100%)
   IDC                   4        4
   DCIS                  7        7
  *Benign*               183      97 (53%)
   Duct ectasia          76       43
   Papilloma             65       36
   Periductal mastitis   21       8
   Fibrocystic disease   12       5
   ADH                   3        2
   Normal                6        4

###### 

Patients with benign diagnoses at duct excision, who subsequently represented with breast cancer.

  Age at original presentation   Initial presentation                        Initial diagnosis                                      Time to re-presentation   Side            Subsequent presentation                                    Further histology                                                  Treatment
  ------------------------------ ------------------------------------------- ------------------------------------------------------ ------------------------- --------------- ---------------------------------------------------------- ------------------------------------------------------------------ -------------------------------------------------------------------------------------------------------------------
  63                             Bloodstained single-duct nipple discharge   ADH                                                    16 months                 Contralateral   Serous nipple discharge dipstick +++ for blood             2 mm grade 2 node negative IDC +DCIS + duct papilloma              Mx + ANC
  77                             Bloodstained single-duct nipple discharge   ADH                                                    48 months                 Ipsilateral     Asymmetric density seen on screening mammogram follow up   16 mm grade 2 node negative IDC                                    Mx + ANC
  49                             Serous single-duct nipple discharge         Duct papilloma, duct ectasia and fibrocystic disease   84 months                 Contralateral   Breast pain and nodularity                                 23 mm grade 2 node negative IDC + DCIS                             Mx + ANC + reconstruction. Recurrence in reconstructio 15 months later treated with WLE + DXT (15 mm grade 3 IDC)
  52                             Bloodstained single-duct nipple discharge   Fibrocystic disease                                    94 months                 Ipsilateral     Lump in axilla                                             Metastatic adenocarcinoma from presumed occult breast primary      ANC
  59                             Bloodstained single-duct nipple discharge   Duct ectasia                                           54 months                 Ipsilateral     Lump                                                       22 mm grade 2 node negative IDC                                    WLE + ANC + DXT
  62                             Brown single-duct nipple discharge          Duct papilloma                                         56 months                 Ipsilateral     Bloodstained nipple discharge                              Two adjacent \<5 mm grade 2 node negative IDC                      Mx + ANC
  67                             Serous single-duct nipple discharge         Duct papilloma                                         26 months                 Contralateral   Bloodstained nipple discharge and nodularity               13 mm grade 2 node negative IDC, DCIS + multiple duct papillomas   WLE + ANS + DXT
  76                             Clear single-duct nipple discharge          Duct papilloma + duct ectasia                          6 weeks                   Contralateral   New lump                                                   14 mm grade 2 node negative IDC                                    Mx + ANC

Histology: DCIS: ductal carcinoma in situ; IDC: Invasive ductal carcinoma.

Treatment: Mx: mastectomy; ANS: axillary node sampling; ANC: axillary node clearance; WLE: wide local excision; DXT: radiotherapy.
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